|
Session 197-Poster Abstracts
HIV Disease Progression
Wednesday, 2-4 pm; Poster Hall |
978
 |
Longitudinal CD4 Cell Count Evolution during HIV Natural History: Comparison between European and Sub-Saharan African Seroconverter Cohorts
N Pantazis1, Charles Morrison*2, P Amornkul3, R Salata4, E Karita5, H Jaffe6, S Lodi7, K Porter7, G Touloumi1, and Hormonal Contraception/Genital Shedding Group, IAVI Early Infections Group and CASCADE Collaboration
1Athens Univ Med Sch, Greece; 2Family Hlth Intl, Durham, NC, US; 3Intl AIDS Vaccine Initiative, San Francisco, CA, US; 4Case Western Reserve Univ, Cleveland, OH, US; 5Projet San Francisco, Kigali, Rwanda; 6Univ of Oxford, UK; and 7Med Res Council, London, UK |
979
|
Differences in Time to AIDS and Death following HIV Seroconversion according to Geographical Origin
Inma Jarrin*1, J Gill2, R Geskus3, L Meyer4, G Touloumi5, M Prins3, O Hamouda6, S Perez-Hoyos7, K Porter8, J del Amo1, and CASCADE
1Inst de Salud Carlos III, Madrid, Spain; 2Univ of Alberta, Edmonton, Canada; 3Academic Med Ctr, Amsterdam, The Netherlands; 4INSERM, Paris, France; 5Athens Univ Sch of Publ Hlth, Greece; 6Robert Koch Inst, Berlin, Germany; 7CRESIB, Barcelona, Spain; and 8Med Res Council Clin Trials Unit, London, UK |
980
|
Are HIV-infected Persons Progressing Faster after HIV Diagnosis over the Epidemic?
N Crum-Cianflone1, Q Ren1,2, L Eberly1,2, A Ganesan1, A Weintrob1, V Marconi1, R Barthel1, Brian Agan*1, and the Infectious Disease Clin Res Prgm HIV Working Group
1Uniformed Svcs Univ of the Hlth Sci, Bethesda, MD, US and 2Univ of Minnesota, Minneapolis, US |
981
|
Heterogeneous Immuno-virological Outcomes in the 81 Patients Enrolled in the ANRS HIV Controllers National Observatory
Faroudy Boufassa*1, A Saez Cirion2, J Lechenadec1, A Tadesse1, V Avettand-Fenoel3, A Venet4, C Rouzioux3, J-F Delfraissy5, O Lambotte5, L Meyer1, and the ANRS EP36 HIV Controllers Study Group
1INSERM U822, Hosp Kremlin-Bicetre, France; 2Inst Pasteur, Paris, France; 3Univ Paris Descartes EA 3620, Hosp Necker, France; 4INSERM U802, Univ Paris-Sud, Le Kremlin-Bicetre, France; and 5Hosp Kremlin-Bicetre, France |
982
|
Late Presentation for HIV Care in the US and Canada
Keri Althoff*1, S Gange1, M Klein2, R Bosch3, R Hogg4, M Horberg5, J Zhang1, R Moore6, and the North American-AIDS Cohort Collaboration on Res and Design
1Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 2McGill Univ Hlth Ctr, Montreal, Canada; 3Harvard Sch of Publ Hlth, Boston, MA, US; 4BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; 5Kaiser Permanente HIV Initiative, Oakland, CA, US; and 6Johns Hopkins Univ Sch of Med, Baltimore, MD, US |
983
|
CD4 at HAART Initiation Predicts Long-term CD4 Responses and Mortality from AIDS and Non-AIDS Causes in the HIV Outpatient Study
Frank Palella*1, C Armon2, K Buchacz3, B Yangco4, J Chmiel1, R Novak5, K Wood2, M Durham3, J Brooks3, and the HOPS Investigators
1Northwestern Univ, Feinberg Sch of Med, Chicago, IL, US; 2Cerner Corp, Vienna, VA, US; 3CDC, Atlanta, GA, US; 4Infectious Disease Res Inst, Tampa, FL, US; and 5Univ of Illinois at Chicago Coll of Med, US |
|
